193 related articles for article (PubMed ID: 23153057)
21. Utility of long-term cultured human hepatocytes as an in vitro model for cytochrome p450 induction.
Meneses-Lorente G; Pattison C; Guyomard C; Chesné C; Heavens R; Watt AP; Sohal B
Drug Metab Dispos; 2007 Feb; 35(2):215-20. PubMed ID: 17093007
[TBL] [Abstract][Full Text] [Related]
22. Induction of cytochrome P450 enzymes in primary equine hepatocyte culture.
Stefanski A; Mevissen M; Möller AM; Kuehni-Boghenbor K; Schmitz A
Toxicol In Vitro; 2013 Oct; 27(7):2023-30. PubMed ID: 23916975
[TBL] [Abstract][Full Text] [Related]
23. Assessment of cytochrome P450 induction in human hepatocytes using the cocktail strategy plus liquid chromatography tandem mass spectrometry.
Lahoz A; Donato MT; Picazo L; Castell JV; Gómez-Lechón MJ
Drug Metab Lett; 2008 Aug; 2(3):205-9. PubMed ID: 19356095
[TBL] [Abstract][Full Text] [Related]
24. Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices.
Martin H; Sarsat JP; de Waziers I; Housset C; Balladur P; Beaune P; Albaladejo V; Lerche-Langrand C
Pharm Res; 2003 Apr; 20(4):557-68. PubMed ID: 12739762
[TBL] [Abstract][Full Text] [Related]
25. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
[TBL] [Abstract][Full Text] [Related]
26. In vitro inhibition and induction of human cytochrome P450 enzymes by mirabegron, a potent and selective β3-adrenoceptor agonist.
Takusagawa S; Miyashita A; Iwatsubo T; Usui T
Xenobiotica; 2012 Dec; 42(12):1187-96. PubMed ID: 22834478
[TBL] [Abstract][Full Text] [Related]
27. Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse.
Dinger J; Meyer MR; Maurer HH
Toxicol Lett; 2014 Oct; 230(1):28-35. PubMed ID: 25111188
[TBL] [Abstract][Full Text] [Related]
28. Refinement of an in vitro cell model for cytochrome P450 induction.
Silva JM; Morin PE; Day SH; Kennedy BP; Payette P; Rushmore T; Yergey JA; Nicoll-Griffith DA
Drug Metab Dispos; 1998 May; 26(5):490-6. PubMed ID: 9571231
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of cytochrome P450 activities in human hepatocytes in vitro.
Gómez-Lechón MJ; Lahoz A; Castell JV; Donato MT
Methods Mol Biol; 2012; 806():87-97. PubMed ID: 22057447
[TBL] [Abstract][Full Text] [Related]
30. Use of a cocktail of probe substrates for drug-metabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations.
Floby E; Briem S; Terelius Y; Sohlenius-Sternbeck AK
Xenobiotica; 2004; 34(11-12):949-59. PubMed ID: 15801540
[TBL] [Abstract][Full Text] [Related]
31. The use of a substrate cassette strategy to improve the capacity and throughput of cytochrome P450 induction studies in human hepatocytes.
Mohutsky MA; Petullo DM; Wrighton SA
Drug Metab Dispos; 2005 Jul; 33(7):920-3. PubMed ID: 15802386
[TBL] [Abstract][Full Text] [Related]
32. A 96-well plate assay for CYP4503A induction using cryopreserved human hepatocytes.
Kamiguchi N; Aoyama E; Okuda T; Moriwaki T
Drug Metab Dispos; 2010 Nov; 38(11):1912-6. PubMed ID: 20699409
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
[TBL] [Abstract][Full Text] [Related]
34. A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS.
Pillai VC; Strom SC; Caritis SN; Venkataramanan R
J Pharm Biomed Anal; 2013 Feb; 74():126-32. PubMed ID: 23245243
[TBL] [Abstract][Full Text] [Related]
35. Induction of CYP2C genes in human hepatocytes in primary culture.
Gerbal-Chaloin S; Pascussi JM; Pichard-Garcia L; Daujat M; Waechter F; Fabre JM; Carrère N; Maurel P
Drug Metab Dispos; 2001 Mar; 29(3):242-51. PubMed ID: 11181490
[TBL] [Abstract][Full Text] [Related]
36. In vitro assessment of cytochrome P450 inhibition and induction potential of tanespimycin and its major metabolite, 17-amino-17-demethoxygeldanamycin.
Gan J; Liu-Kreyche P; Humphreys WG
Cancer Chemother Pharmacol; 2012 Jan; 69(1):51-6. PubMed ID: 21594721
[TBL] [Abstract][Full Text] [Related]
37. Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin.
Babbar S; Chanda S; Bley K
Xenobiotica; 2010 Dec; 40(12):807-16. PubMed ID: 20863199
[TBL] [Abstract][Full Text] [Related]
38. Cryopreserved porcine hepatocytes: expression and induction of cytochrome P450, isoform CYP2E1.
Baldini E; Cursio R; Desousa G; Margara A; Honiger J; Saint-Paul MC; Bayer P; Raimondi V; Rahmani R; Mouiel J; Gugenheim J
Transplant Proc; 2009 May; 41(4):1367-9. PubMed ID: 19460561
[TBL] [Abstract][Full Text] [Related]
39. In vitro assessment of cytochrome P450 inhibition and induction potential of felotaxel (SHR110008).
Ding Y; Jia Y; Lu C; Liu W; Yang J; Song Y; Zhu Y; Yang L; Ding L; Wen A
Biomed Pharmacother; 2012 Jun; 66(4):318-21. PubMed ID: 22397757
[TBL] [Abstract][Full Text] [Related]
40. Automated triplexed hepatocyte-based viability and CYP1A and -3A induction assays.
Larson B; Moeller T; Banks P; Cali JJ
J Biomol Screen; 2011 Sep; 16(8):895-902. PubMed ID: 21693767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
